Skip to main content
Journal cover image

Performance of a proteomic preterm delivery predictor in a large independent prospective cohort.

Publication ,  Journal Article
Markenson, GR; Saade, GR; Laurent, LC; Heyborne, KD; Coonrod, DV; Schoen, CN; Baxter, JK; Haas, DM; Longo, S; Grobman, WA; Sullivan, SA ...
Published in: Am J Obstet Gynecol MFM
August 2020

BACKGROUND: Preterm birth remains a common and devastating complication of pregnancy. There remains a need for effective and accurate screening methods for preterm birth. Using a proteomic approach, we previously discovered and validated (Proteomic Assessment of Preterm Risk study, NCT01371019) a preterm birth predictor comprising a ratio of insulin-like growth factor-binding protein 4 to sex hormone-binding globulin. OBJECTIVE: To determine the performance of the ratio of insulin-like growth factor-binding protein 4 to sex hormone-binding globulin to predict both spontaneous and medically indicated very preterm births, in an independent cohort distinct from the one in which it was developed. STUDY DESIGN: This was a prospective observational study (Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor, NCT02787213) at 18 sites in the United States. Women had blood drawn at 170/7 to 216/7 weeks' gestation. For confirmation, we planned to analyze a randomly selected subgroup of women having blood drawn between 191/7 and 206/7 weeks' gestation, with the results of the remaining study participants blinded for future validation studies. Serum from participants was analyzed by mass spectrometry. Neonatal morbidity and mortality were analyzed using a composite score by a method from the PREGNANT trial (NCT00615550, Hassan et al). Scores of 0-3 reflect increasing numbers of morbidities or length of neonatal intensive care unit stay, and 4 represents perinatal mortality. RESULTS: A total of 5011 women were enrolled, with 847 included in this planned substudy analysis. There were 9 preterm birth cases at <320/7 weeks' gestation and 838 noncases at ≥320/7 weeks' gestation; 21 of 847 infants had neonatal composite morbidity and mortality index scores of ≥3, and 4 of 21 had a score of 4. The ratio of insulin-like growth factor-binding protein 4 to sex hormone-binding globulin ratio was substantially higher in both preterm births at <320/7 weeks' gestation and there were more severe neonatal outcomes. The ratio of insulin-like growth factor-binding protein 4 to sex hormone-binding globulin ratio was significantly predictive of birth at <320/7 weeks' gestation (area under the receiver operating characteristic curve, 0.71; 95% confidence interval, 0.55-0.87; P=.016). Stratification by body mass index, optimized in the previous validation study (22

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Obstet Gynecol MFM

DOI

EISSN

2589-9333

Publication Date

August 2020

Volume

2

Issue

3

Start / End Page

100140

Location

United States

Related Subject Headings

  • United States
  • Proteomics
  • Prospective Studies
  • Premature Birth
  • Pregnancy
  • Infant, Newborn
  • Humans
  • Gestational Age
  • Female
  • Cohort Studies
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Markenson, G. R., Saade, G. R., Laurent, L. C., Heyborne, K. D., Coonrod, D. V., Schoen, C. N., … Lam, G. K. (2020). Performance of a proteomic preterm delivery predictor in a large independent prospective cohort. Am J Obstet Gynecol MFM, 2(3), 100140. https://doi.org/10.1016/j.ajogmf.2020.100140
Markenson, Glenn R., George R. Saade, Louise C. Laurent, Kent D. Heyborne, Dean V. Coonrod, Corina N. Schoen, Jason K. Baxter, et al. “Performance of a proteomic preterm delivery predictor in a large independent prospective cohort.Am J Obstet Gynecol MFM 2, no. 3 (August 2020): 100140. https://doi.org/10.1016/j.ajogmf.2020.100140.
Markenson GR, Saade GR, Laurent LC, Heyborne KD, Coonrod DV, Schoen CN, et al. Performance of a proteomic preterm delivery predictor in a large independent prospective cohort. Am J Obstet Gynecol MFM. 2020 Aug;2(3):100140.
Markenson, Glenn R., et al. “Performance of a proteomic preterm delivery predictor in a large independent prospective cohort.Am J Obstet Gynecol MFM, vol. 2, no. 3, Aug. 2020, p. 100140. Pubmed, doi:10.1016/j.ajogmf.2020.100140.
Markenson GR, Saade GR, Laurent LC, Heyborne KD, Coonrod DV, Schoen CN, Baxter JK, Haas DM, Longo S, Grobman WA, Sullivan SA, Major CA, Wheeler SM, Pereira LM, Su EJ, Boggess KA, Hawk AF, Crockett AH, Fox AC, Polpitiya A, Fleischer TC, Critchfield GC, Burchard J, Boniface JJ, Lam GK. Performance of a proteomic preterm delivery predictor in a large independent prospective cohort. Am J Obstet Gynecol MFM. 2020 Aug;2(3):100140.
Journal cover image

Published In

Am J Obstet Gynecol MFM

DOI

EISSN

2589-9333

Publication Date

August 2020

Volume

2

Issue

3

Start / End Page

100140

Location

United States

Related Subject Headings

  • United States
  • Proteomics
  • Prospective Studies
  • Premature Birth
  • Pregnancy
  • Infant, Newborn
  • Humans
  • Gestational Age
  • Female
  • Cohort Studies